[{"Physician_Profile_ID": "708876", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "300.00", "Date_of_Payment": "11/01/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "24479911", "Name_of_Associated_Covered_Drug_or_Biological1": "IMPLANON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Post authorization safety study IMPLANON NXT observational cohort study", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "708876", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "200.00", "Date_of_Payment": "01/10/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "212922440", "Name_of_Associated_Covered_Drug_or_Biological1": "IMPLANON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Post authorization safety study IMPLANON NXT observational cohort study", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "708876", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "150.00", "Date_of_Payment": "04/08/2015", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "332049283", "Name_of_Associated_Covered_Drug_or_Biological1": "IMPLANON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Nexplanon Observational Risk Assessment Study NORA", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "708876", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "100.00", "Date_of_Payment": "12/10/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "24474412", "Name_of_Associated_Covered_Drug_or_Biological1": "IMPLANON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Post authorization safety study IMPLANON NXT observational cohort study", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "708876", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "100.00", "Date_of_Payment": "10/03/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "24479910", "Name_of_Associated_Covered_Drug_or_Biological1": "IMPLANON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Post authorization safety study IMPLANON NXT observational cohort study", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "708876", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "100.00", "Date_of_Payment": "08/02/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "24469709", "Name_of_Associated_Covered_Drug_or_Biological1": "IMPLANON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Post authorization safety study IMPLANON NXT observational cohort study", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "708876", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Merck Sharp & Dohme Corporation", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000053", "Total_Amount_of_Payment_USDollars": "50.00", "Date_of_Payment": "12/11/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "212909994", "Name_of_Associated_Covered_Drug_or_Biological1": "IMPLANON", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Nexplanon Observational Risk Assessment Study NORA", "Research_Information_Link": "", "Context_of_Research": ""}]